Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 26;8(3):122-126.
doi: 10.9740/mhc.2018.05.122. eCollection 2018 May.

Antipsychotic discontinuation after the initiation of selective serotonin reuptake inhibitors therapy for the treatment of behavioral and psychological symptoms associated with dementia

Monica Mathys  1 , Steven Fang  2 , Jini John  2 , Jasmine Carter  2
Affiliations

Antipsychotic discontinuation after the initiation of selective serotonin reuptake inhibitors therapy for the treatment of behavioral and psychological symptoms associated with dementia

Monica Mathys et al. Ment Health Clin. .

Abstract

Introduction: Antipsychotics are used off label to treat behavioral and psychological symptoms of dementia (BPSD). Due to the emerging data of selective serotonin reuptake inhibitors (SSRIs) for treatment of BPSD, clinicians may choose to use this medication class instead of antipsychotics when pharmacologic therapy is necessary. The objective of this study was to evaluate the prevalence of antipsychotic discontinuation 6 months after SSRI initiation for the treatment of BPSD.

Methods: Patients with Alzheimer dementia who were prescribed an antipsychotic and later prescribed an SSRI for BPSD during January 1, 2009, through December 30, 2014, were studied. Exclusion criteria included (1) a dementia diagnosis besides Alzheimer; (2) scheduled benzodiazepines, mood stabilizers, or non-SSRI antidepressant use during the study period; (3) diagnoses of bipolar or psychotic disorders; and (4) diagnosis of delirium during the study period. Patients' age, sex, race, and functional assessment of staging for Alzheimer disease scores were collected. The names, doses, and stop dates of SSRIs and antipsychotics were also recorded.

Results: Thirty-six patients were included in the analyses. Overall, antipsychotic use was reduced in 11 patients (30.6%). Ten patients (27.8%) discontinued the antipsychotic, and 1 additional patient had a reduction in dose. When comparing specific SSRIs, 8 (72%) responders were prescribed citalopram, and 15 (60%) nonresponders were prescribed sertraline.

Discussion: Approximately 30% of patients with Alzheimer dementia who were prescribed antipsychotics for BPSD were able to discontinue the medication or had a dose reduction after starting SSRI therapy. Most SSRI responders were prescribed citalopram.

Keywords: antipsychotics; behavioral symptoms; dementia; psychological symptoms; selective serotonin reuptake inhibitors; use reduction.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors report no conflicts of interest.

References

    1. Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. . Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement. 2011; 7 5: 532- 9. DOI: 10.1016/j.jalz.2011.05.2410. PubMed PMID: 21889116; PubMed Central PMCID: PMC3299979. - DOI - PMC - PubMed
    1. Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. . Behavioral and psychological symptoms of dementia. Front Neurol. 2012; 3: 73 DOI: 10.3389/fneur.2012.00073. PubMed PMID: 22586419; PubMed Central PMCID: PMC3345875. - DOI - PMC - PubMed
    1. Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, et al. . Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study. Acta Clin Belg. 2007; 62 6: 426- 32. DOI: 10.1179/acb.2007.062. PubMed PMID: 18351187. - DOI - PubMed
    1. Azermai M. . Dealing with behavioral and psychological symptoms of dementia: a general overview. Psychol Res Behav Manag. 2015; 8: 181- 5. DOI: 10.2147/PRBM.S44775. PubMed PMID: 26170729; PubMed Central PMCID: PMC4498729. - DOI - PMC - PubMed
    1. Schneider LS, Dagerman KS, Insel P. . Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005; 294 15: 1934- 43. DOI: 10.1001/jama.294.15.1934. PubMed PMID: 16234500. - DOI - PubMed

LinkOut - more resources